Presenilin-1 Explained

Presenilin-1 (PS-1) is a presenilin protein that in humans is encoded by the PSEN1 gene.[1] Presenilin-1 is one of the four core proteins in the gamma secretase complex, which is considered to play an important role in generation of amyloid beta (Aβ) from amyloid-beta precursor protein (APP). Accumulation of amyloid beta is associated with the onset of Alzheimer's disease.[2]

Structure

Presenilin possesses a 9 transmembrane domain topology, with an extracellular C-terminus and a cytosolic N-terminus.[3] [4] Presenilin undergoes endo-proteolytic processing to produce ~27-28 kDa N-terminal and ~16-17 kDa C-terminal fragments in humans.[5] Furthermore, presenilin exists in the cell mainly as a heterodimer of the C-terminal and N-terminus fragments.[5] When presenilin 1 is overexpressed, the full length protein accumulates in an inactive form.[6] Based on evidence that a gamma-secretase inhibitor binds to the fragments,[7] the cleaved presenilin complex is considered to be the active form.[8]

Function

Presenilins are postulated to regulate APP processing through their effects on gamma secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma secretase activity or themselves are protease enzymes. Multiple alternatively spliced transcript variants have been identified for this gene, the full-length natures of only some have been determined.[9]

Notch signaling pathway

In Notch signaling, critical proteolytic reactions takes place during maturation and activation of Notch membrane receptor.[10] Notch1 is cleaved extracellularlly at site1 (S1) and two polypeptides are produced to form a heterodimer receptor on the cell surface.[11] After the formation of receptor, Notch1 is further cleaved in site 3(S3)[12] and release Notch1 intracellular domain (NICD) from the membrane.[13]

Presenilin 1 has been shown to play an important role in proteolytic process. In the prenilin 1 null mutant drosophila, Notch signaling is abolished and it displays a notch-like lethal phenotype.[14] Moreover, in mammalian cells, deficiency of PSEN1 also causes the defect in the proteolytic release of NICD from a truncated Notch construct. The same step can be also blocked by several gamma-secretase inhibitors, shown in the same study.[15] These evidences collectively suggest a critical role of presenilin 1 in the Notch signaling pathway.

Wnt signaling pathway

Wnt signaling pathway has been shown to be involved in several critical steps in embryogenesis and development. Presenilin 1 has been shown to form a complex with beta-catenin, an important component in Wnt signaling, and stabilize beta-catenin.[16] Mutant of presenilin-1 that reduces the ability to stabilize beta-catenin complex leads to hyperactive degradation of beta-catenin in the brains of transgenic mice.[16]

Considered as a negative regulator in wnt signaling pathway, presenilin-1 was also found to play a role in beta-catenin phosphorylation.[17] Beta-catenin is coupled by presenilin-1 and undergoes a sequential phosphorylation by two kinase activities.[17] The study also further illustrates that the deficiency of presenilin 1 disconnects the sequential phosphorylation and thus disrupts the normal wnt signaling pathway.[17]

Clinical significance

Beta-amyloid production

Transgenic mice that over-expressed mutant presenilin-1 show an increase of beta-amyloid-42(43) in the brain, which suggest presenilin-1 plays an important role in beta-amyloid regulation and can be highly related to Alzheimer's disease.[18] Further study conducted in neuronal cultures derived from presenilin-1 deficient mouse embryos showed that cleavage by alpha- and beta- secretase was still normal without the presence of presenilin-1. Meanwhile, when the cleavage by gamma-cleavage of the transmembrane domain of APP was abolished a 5-fold drop of amyloid peptide was observed, suggesting that deficiency of presenilin-1 can downregulate amyloid and inhibition of presenilin-1 can be a potential method for anti-amyloidogenic therapy in Alzheimer's disease.[19] Extensive study on the role of presenilin-1 in amyloid production has been conducted to improve our understanding of Alzheimer's disease.[20] [21]

Alzheimer's disease

Alzheimer's disease (AD) patients with an inherited form of the disease may carry mutations in the presenilin proteins (PSEN1; PSEN2) or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid beta (main component of amyloid deposits found in AD brains). These mutations result in early-onset Alzheimer's Disease, which is a rare form of the disease. These rare genetic variants are autosomal dominant.[22]

Cancer

In addition to its role in Alzheimer's disease, presenilin-1 also found to be important in cancer. A study of broad range gene expression was conducted on human malignant melanoma. Researchers classified the malignant melanoma cell lines into two types. The study showed that presenilin-1 is down regulated in this cell type while it is overexpressed in the other cell type.[23] Another study on multidrug resistance (MDR) cell line also reveals a role of presenilin-1 in cancer development. Because of the development to the resistance to chemicals, MDR cells become a critical factor on the success of cancer chemotherapy.[24] In the study, researchers tried to explore the molecular mechanism by looking into the expression of Notch1 intracellular (N1IC) domain and presenilin 1. They found that there is higher level expression of both proteins and a multidrug resistance-associated protein 1 (ABCC1) was also found to be regulated by N1IC, which suggest a mechanism of ABCC1 regulated by presenilin 1 and notch signaling.[25]

Interactions

PSEN1 has been shown to interact with:

Further reading

External links

Notes and References

  1. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME . Genetic linkage evidence for a familial Alzheimer's seasesease locus on chromosome 14 . Science . 258 . 5082 . 668–71 . Nov 1992 . 1411576 . 10.1126/science.1411576 . 1992Sci...258..668S .
  2. Selkoe DJ . Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease . Annu. Rev. Cell Biol. . 10 . 373–403 . 1994 . 7888181 . 10.1146/annurev.cb.10.110194.002105 .
  3. Laudon H, Hansson EM, Melén K, Bergman A, Farmery MR, Winblad B, Lendahl U, von Heijne G, Näslund J . A nine-transmembrane domain topology for presenilin 1 . J. Biol. Chem. . 280 . 42 . 35352–60 . October 2005 . 16046406 . 10.1074/jbc.M507217200 . free .
  4. Spasic D, Annaert W . Building gamma-secretase: the bits and pieces . J. Cell Sci. . 121 . Pt 4 . 413–20 . February 2008 . 18256384 . 10.1242/jcs.015255 . free .
  5. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS . Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo . Neuron . 17 . 1 . 181–90 . July 1996 . 8755489 . 10.1016/S0896-6273(00)80291-3 . free .
  6. Ratovitski T, Slunt HH, Thinakaran G, Price DL, Sisodia SS, Borchelt DR . Endoproteolytic processing and stabilization of wild-type and mutant presenilin . J. Biol. Chem. . 272 . 39 . 24536–41 . September 1997 . 9305918 . 10.1074/jbc.272.39.24536 . free .
  7. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, Harrison T, Lellis C, Nadin A, Neduvelil JG, Register RB, Sardana MK, Shearman MS, Smith AL, Shi XP, Yin KC, Shafer JA, Gardell SJ . Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1 . Nature . 405 . 6787 . 689–94 . June 2000 . 10864326 . 10.1038/35015085 . 2000Natur.405..689L . 4420032 .
  8. Brunkan AL, Martinez M, Walker ES, Goate AM . Presenilin endoproteolysis is an intramolecular cleavage . Mol. Cell. Neurosci. . 29 . 1 . 65–73 . May 2005 . 15866047 . 10.1016/j.mcn.2004.12.012 . 37048469 .
  9. Web site: Entrez Gene: PSEN1 presenilin 1 (Alzheimer disease 3).
  10. Chan YM, Jan YN . Roles for proteolysis and trafficking in notch maturation and signal transduction . Cell . 94 . 4 . 423–6 . August 1998 . 9727485 . 10.1016/S0092-8674(00)81583-4 . free .
  11. Logeat F, Bessia C, Brou C, LeBail O, Jarriault S, Seidah NG, Israël A . The Notch1 receptor is cleaved constitutively by a furin-like convertase . Proc. Natl. Acad. Sci. U.S.A. . 95 . 14 . 8108–12 . July 1998 . 9653148 . 20937 . 10.1073/pnas.95.14.8108 . 1998PNAS...95.8108L . free .
  12. Schroeter EH, Kisslinger JA, Kopan R . Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain . Nature . 393 . 6683 . 382–6 . May 1998 . 9620803 . 10.1038/30756 . 1998Natur.393..382S . 4431882 .
  13. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A . Signalling downstream of activated mammalian Notch . Nature . 377 . 6547 . 355–8 . September 1995 . 7566092 . 10.1038/377355a0 . 1995Natur.377..355J . 4269110 .
  14. Struhl G, Greenwald I . Presenilin is required for activity and nuclear access of Notch in Drosophila . Nature . 398 . 6727 . 522–5 . April 1999 . 10206646 . 10.1038/19091 . 1999Natur.398..522S . 4392625 .
  15. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R . A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain . Nature . 398 . 6727 . 518–22 . April 1999 . 10206645 . 10.1038/19083 . 1999Natur.398..518D . 4346474 .
  16. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Südhof TC, Shen J . Presenilins are essential for regulating neurotransmitter release . Nature . 460 . 7255 . 632–6 . July 2009 . 19641596 . 2744588 . 10.1038/nature08177 . 2009Natur.460..632Z .
  17. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, Zheng H, Koo EH . Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis . Cell . 110 . 6 . 751–62 . September 2002 . 12297048 . 10.1016/S0092-8674(02)00970-4 . free .
  18. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S . Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1 . Nature . 383 . 6602 . 710–3 . October 1996 . 8878479 . 10.1038/383710a0 . 1996Natur.383..710D . 4339658 .
  19. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F . Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein . Nature . 391 . 6665 . 387–90 . January 1998 . 9450754 . 10.1038/34910 . 1998Natur.391..387D . 4397720 .
  20. Pitsi D, Octave JN . Presenilin 1 stabilizes the C-terminal fragment of the amyloid precursor protein independently of gamma-secretase activity . J. Biol. Chem. . 279 . 24 . 25333–8 . June 2004 . 15087467 . 10.1074/jbc.M312710200 . free .
  21. Phiel CJ, Wilson CA, Lee VM, Klein PS . GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides . Nature . 423 . 6938 . 435–9 . May 2003 . 12761548 . 10.1038/nature01640 . 2003Natur.423..435P . 4416851 .
  22. Yaakov Stern . Mayeux R, Stern Y . Epidemiology of Alzheimer disease . Cold Spring Harbor Perspectives in Medicine . 2 . 8 . a006239. 2012 . 22908189 . 3405821 . 10.1101/cshperspect.a006239 .
  23. Su DM, Zhang Q, Wang X, He P, Zhu YJ, Zhao J, Rennert OM, Su YA . Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy . Mol. Cancer Ther. . 8 . 5 . 1292–304 . May 2009 . 19383853 . 3128982 . 10.1158/1535-7163.MCT-08-1030 .
  24. Gottesman MM, Fojo T, Bates SE . Multidrug resistance in cancer: role of ATP-dependent transporters . Nat. Rev. Cancer . 2 . 1 . 48–58 . January 2002 . 11902585 . 10.1038/nrc706 . 34650170 .
  25. Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, Beck WT . Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells . Proc. Natl. Acad. Sci. U.S.A. . 108 . 51 . 20778–83 . December 2011 . 22143792 . 3251103 . 10.1073/pnas.1019452108 . 2011PNAS..10820778C . free .
  26. Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G . Presenilin 1 protein directly interacts with Bcl-2 . J. Biol. Chem. . 274 . 43 . 30764–9 . October 1999 . 10521466 . 10.1074/jbc.274.43.30764 . free .
  27. Tesco G, Kim TW, Diehlmann A, Beyreuther K, Tanzi RE . Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation . J. Biol. Chem. . 273 . 51 . 33909–14 . December 1998 . 9852041 . 10.1074/jbc.273.51.33909 . free .
  28. Kang DE, Soriano S, Frosch MP, Collins T, Naruse S, Sisodia SS, Leibowitz G, Levine F, Koo EH . Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway . J. Neurosci. . 19 . 11 . 4229–37 . June 1999 . 10341227 . 10.1523/JNEUROSCI.19-11-04229.1999 . 6782616.
  29. Murayama M, Tanaka S, Palacino J, Murayama O, Honda T, Sun X, Yasutake K, Nihonmatsu N, Wolozin B, Takashima A . Benjamin Wolozin . Direct association of presenilin-1 with beta-catenin . FEBS Lett. . 433 . 1–2 . 73–7 . August 1998 . 9738936 . 10.1016/S0014-5793(98)00886-2 . 85416623 .
  30. Tanahashi H, Tabira T . Isolation of human delta-catenin and its binding specificity with presenilin 1 . NeuroReport . 10 . 3 . 563–8 . February 1999 . 10208590 . 10.1097/00001756-199902250-00022 .
  31. Zhang W, Han SW, McKeel DW, Goate A, Wu JY . Interaction of presenilins with the filamin family of actin-binding proteins . J. Neurosci. . 18 . 3 . 914–22 . February 1998 . 9437013 . 2042137 . 10.1523/JNEUROSCI.18-03-00914.1998.
  32. Nielsen AL, Holm IE, Johansen M, Bonven B, Jørgensen P, Jørgensen AL . A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins . J. Biol. Chem. . 277 . 33 . 29983–91 . August 2002 . 12058025 . 10.1074/jbc.M112121200 . free .
  33. Levesque G. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin.. Journal of Neurochemistry. 1999. 72. 3. 999–1008. 10037471. 10.1046/j.1471-4159.1999.0720999.x. 36124450 .
  34. Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, Cupers P, Craessaerts K, De Strooper B . Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins . Neuron . 32 . 4 . 579–89 . November 2001 . 11719200 . 10.1016/S0896-6273(01)00512-8 . free .
  35. Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, Wasco W . Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment . Nat. Med. . 4 . 10 . 1177–81 . October 1998 . 9771752 . 10.1038/2673 . 10799492 .
  36. Kashiwa A, Yoshida H, Lee S, Paladino T, Liu Y, Chen Q, Dargusch R, Schubert D, Kimura H . Isolation and characterization of novel presenilin binding protein . J. Neurochem. . 75 . 1 . 109–16 . July 2000 . 10854253 . 10.1046/j.1471-4159.2000.0750109.x .
  37. Haffner C, Frauli M, Topp S, Irmler M, Hofmann K, Regula JT, Bally-Cuif L, Haass C . Nicalin and its binding partner Nomo are novel Nodal signaling antagonists . EMBO J. . 23 . 15 . 3041–50 . August 2004 . 15257293 . 514924 . 10.1038/sj.emboj.7600307 .
  38. Baulac S, LaVoie MJ, Kimberly WT, Strahle J, Wolfe MS, Selkoe DJ, Xia W . Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates . Neurobiol. Dis. . 14 . 2 . 194–204 . November 2003 . 14572442 . 10.1016/S0969-9961(03)00123-2 . 10.1.1.624.6715 . 53205510 .
  39. Gu Y, Chen F, Sanjo N, Kawarai T, Hasegawa H, Duthie M, Li W, Ruan X, Luthra A, Mount HT, Tandon A, Fraser PE, St George-Hyslop P . APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes . J. Biol. Chem. . 278 . 9 . 7374–80 . February 2003 . 12471034 . 10.1074/jbc.M209499200 . free .
  40. Lee SF, Shah S, Li H, Yu C, Han W, Yu G . Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch . J. Biol. Chem. . 277 . 47 . 45013–9 . November 2002 . 12297508 . 10.1074/jbc.M208164200 . free .
  41. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P . Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing . Nature . 407 . 6800 . 48–54 . September 2000 . 10993067 . 10.1038/35024009 . 2000Natur.407...48Y . 4339220 .
  42. Stahl B, Diehlmann A, Südhof TC . Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071 . J. Biol. Chem. . 274 . 14 . 9141–8 . April 1999 . 10092585 . 10.1074/jbc.274.14.9141 . free .
  43. Mah AL, Perry G, Smith MA, Monteiro MJ . Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation . J. Cell Biol. . 151 . 4 . 847–62 . November 2000 . 11076969 . 2169435 . 10.1083/jcb.151.4.847 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Presenilin-1".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.